vs
Side-by-side financial comparison of GCM Grosvenor Inc. (GCMG) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
GCM Grosvenor Inc. is the larger business by last-quarter revenue ($177.1M vs $158.6M, roughly 1.1× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 32.8%, a 38.3% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 7.2%). GCM Grosvenor Inc. produced more free cash flow last quarter ($175.0M vs $131.7M).
GCM Grosvenor is an American alternative asset management firm, with approximately $76 billion in assets under management and approximately 530 professionals as of 2023.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
GCMG vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $177.1M | $158.6M |
| Net Profit | $58.2M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 30.9% | 70.2% |
| Net Margin | 32.8% | 71.2% |
| Revenue YoY | 7.2% | 3661.1% |
| Net Profit YoY | 149.2% | 528.0% |
| EPS (diluted) | $0.23 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $177.1M | — | ||
| Q3 25 | $135.0M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $125.8M | $158.6M | ||
| Q4 24 | $165.3M | $22.6M | ||
| Q3 24 | $122.9M | — | ||
| Q2 24 | $117.0M | — | ||
| Q1 24 | $108.9M | — |
| Q4 25 | $58.2M | — | ||
| Q3 25 | $10.5M | — | ||
| Q2 25 | $15.4M | — | ||
| Q1 25 | $463.0K | $112.9M | ||
| Q4 24 | $7.6M | $-10.5M | ||
| Q3 24 | $4.2M | — | ||
| Q2 24 | $4.8M | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | 30.9% | — | ||
| Q3 25 | 32.7% | — | ||
| Q2 25 | 16.1% | — | ||
| Q1 25 | 12.2% | 70.2% | ||
| Q4 24 | 26.4% | -60.4% | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 17.8% | — | ||
| Q1 24 | -14.7% | — |
| Q4 25 | 32.8% | — | ||
| Q3 25 | 7.8% | — | ||
| Q2 25 | 12.9% | — | ||
| Q1 25 | 0.4% | 71.2% | ||
| Q4 24 | 4.6% | -46.4% | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.16 | — | ||
| Q2 25 | $0.05 | — | ||
| Q1 25 | $-0.02 | $1.90 | ||
| Q4 24 | $0.09 | $-0.15 | ||
| Q3 24 | $0.03 | — | ||
| Q2 24 | $0.04 | — | ||
| Q1 24 | $-0.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.1M | $274.8M |
| Total DebtLower is stronger | $428.4M | — |
| Stockholders' EquityBook value | $27.0M | $350.1M |
| Total Assets | $813.8M | $406.9M |
| Debt / EquityLower = less leverage | 15.87× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.1M | — | ||
| Q3 25 | $182.7M | — | ||
| Q2 25 | $136.3M | — | ||
| Q1 25 | $94.5M | $274.8M | ||
| Q4 24 | $89.5M | $128.0M | ||
| Q3 24 | $98.4M | — | ||
| Q2 24 | $73.9M | — | ||
| Q1 24 | $41.9M | — |
| Q4 25 | $428.4M | — | ||
| Q3 25 | $429.3M | — | ||
| Q2 25 | $430.2M | — | ||
| Q1 25 | $431.1M | — | ||
| Q4 24 | $432.0M | — | ||
| Q3 24 | $432.9M | — | ||
| Q2 24 | $433.8M | — | ||
| Q1 24 | $384.0M | — |
| Q4 25 | $27.0M | — | ||
| Q3 25 | $-7.4M | — | ||
| Q2 25 | $-12.3M | — | ||
| Q1 25 | $-28.3M | $350.1M | ||
| Q4 24 | $-27.6M | $229.0M | ||
| Q3 24 | $-31.9M | — | ||
| Q2 24 | $-28.5M | — | ||
| Q1 24 | $-26.4M | — |
| Q4 25 | $813.8M | — | ||
| Q3 25 | $685.9M | — | ||
| Q2 25 | $636.9M | — | ||
| Q1 25 | $579.8M | $406.9M | ||
| Q4 24 | $612.7M | $271.6M | ||
| Q3 24 | $575.0M | — | ||
| Q2 24 | $543.9M | — | ||
| Q1 24 | $497.3M | — |
| Q4 25 | 15.87× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.5M | $131.8M |
| Free Cash FlowOCF − Capex | $175.0M | $131.7M |
| FCF MarginFCF / Revenue | 98.8% | 83.0% |
| Capex IntensityCapex / Revenue | 4.8% | 0.1% |
| Cash ConversionOCF / Net Profit | 3.16× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $326.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.5M | — | ||
| Q3 25 | $79.8M | — | ||
| Q2 25 | $42.0M | — | ||
| Q1 25 | $33.3M | $131.8M | ||
| Q4 24 | $148.8M | $-23.2M | ||
| Q3 24 | $69.0M | — | ||
| Q2 24 | $17.5M | — | ||
| Q1 24 | $24.2M | — |
| Q4 25 | $175.0M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $40.8M | — | ||
| Q1 25 | $32.1M | $131.7M | ||
| Q4 24 | $132.0M | $-23.2M | ||
| Q3 24 | $62.2M | — | ||
| Q2 24 | $12.8M | — | ||
| Q1 24 | $20.0M | — |
| Q4 25 | 98.8% | — | ||
| Q3 25 | 58.0% | — | ||
| Q2 25 | 34.1% | — | ||
| Q1 25 | 25.5% | 83.0% | ||
| Q4 24 | 79.9% | -102.7% | ||
| Q3 24 | 50.6% | — | ||
| Q2 24 | 10.9% | — | ||
| Q1 24 | 18.4% | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 10.1% | 0.2% | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 3.9% | — |
| Q4 25 | 3.16× | — | ||
| Q3 25 | 7.61× | — | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | 71.84× | 1.17× | ||
| Q4 24 | 19.54× | — | ||
| Q3 24 | 16.60× | — | ||
| Q2 24 | 3.64× | — | ||
| Q1 24 | 11.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCMG
| Asset Management1 | $108.6M | 61% |
| Management Service Incentive Performance Fees | $61.7M | 35% |
| Management Service Incentive Carried Interest | $5.1M | 3% |
| Service Other | $1.8M | 1% |
STOK
Segment breakdown not available.
